Co‐amplified with PDGFRA, IGFBP7 is a prognostic biomarker correlated with the immune infiltrations of glioma
Abstract Background A subgroup of glioma carry genetic 4q12 amplification including platelet derived growth factor receptor α (PDGFRA) and insulin like growth factor binding protein 7 (IGFBP7). However, the prognosis of PDGFRA and IGFBP7 in glioma is unclear. Methods The prognosis of PDGFRA and IGFB...
Main Authors: | Haiwei Wang, Xinrui Wang, Liangpu Xu, Ji Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5187 |
Similar Items
-
New natural compound inhibitors of PDGFRA (platelet-derived growth factor receptor α) based on computational study for high−grade glioma therapy
by: Wenzhuo Yang, et al.
Published: (2023-01-01) -
Prognostic biomarker SGSM1 and its correlation with immune infiltration in gliomas
by: Junsheng Li, et al.
Published: (2022-04-01) -
Pediatric-type high-grade gliomas with PDGFRA amplification in adult patients with Li-Fraumeni syndrome: clinical and molecular characterization of three cases
by: Yuji Kibe, et al.
Published: (2024-04-01) -
A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma
by: Jinhui Liu, et al.
Published: (2022-07-01) -
Rare Pediatric Cerebellar High-Grade Gliomas Mimic Medulloblastomas Histologically and Transcriptomically and Show p53 Mutations
by: Zhi-Feng Shi, et al.
Published: (2024-01-01)